<unk>  is contraindicated in individuals who are taking strong inhibitors of the liver enzyme CYP3A4 (ketoconazole, clarithromycin, ritonavir, levodropropizine, etc.) or inducers (carbamazepine, St. John's wort, phenytoin, rifampicin etc.). The use of<unk>  in pregnant women has not been studied and is not recommended; in animal studies, no risks have been found. Excretion in breast milk is also unknown;<unk>  is not recommended for breastfeeding women. In the United States it is not indicated for use in children.
Lurasidone
Rimonabant
Pirfenidone
Belinostat
Pirlindole
Family therapy
Lorpiprazole
Chlortalidone